Darren G. Woodside, PhD
Darren Woodside, Ph.D., er vicepræsident for forskning og direktør for flowcytometri og billeddannelseskerne ved Texas Heart Institute.
Vis hele bioDr. Woodsides forskning er centreret omkring den rolle, som celleadhæsion spiller i kardiovaskulære og autoimmune sygdomme, og udviklingen af nye metoder til at identificere og behandle disse sygdomme. Før han tiltrådte stillingen som Vice President, fungerede han som Associate Director for Molecular Cardiology Research Laboratories på THI og Associate Director for Drug Discovery hos Encysive Pharmaceuticals. Han fik sin ph.d. fra University of Texas MD Anderson Cancer Center's Department of Immunology og var post-doc ved The Scripps Research Institute.
Han har forfattet adskillige publikationer, tjent i redaktionelle revisionsudvalg og er i øjeblikket formand for NIH Innovative Immunology Study Section.
Skjul hele bio
Texas Heart Institute-stillinger
- Vicepræsident for forskning, Administration
- Instruktør, flowcytometri og billeddannelse, Molekylær kardiologisk forskning
Interesser
- Betændelse
- Ikke-invasive billeddiagnostiske teknologier
Uddannelse
-
Undergraduate:
Queen's University i Kingston
-
Postgraduate:
University of Texas MD Anderson Cancer Center, Graduate School of Biomedical Sciences
-
stipendier:
Scripps Research Institute
Hæder, priser og medlemskaber
Publikationer
4862227
7XFQVVGN
1
alternativer til dyreforsøg
10
dato
desc
Woodside
2170
https://www.texasheart.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22R9HMJE4Q%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pogostin%20et%20al.%22%2C%22parsedDate%22%3A%222022-09-14%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BPogostin%2C%20B.%20H.%2C%20Yu%2C%20M.%20H.%2C%20Azares%2C%20A.%20R.%20et%20al.%20%282022%29.%20Multidomain%20peptide%20hydrogel%20adjuvants%20elicit%20strong%20bias%20towards%20humoral%20immunity.%20%26lt%3Bi%26gt%3BBiomater%20Sci%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1039%5C%2Fd2bm01242a%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1039%5C%2Fd2bm01242a%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Multidomain%20peptide%20hydrogel%20adjuvants%20elicit%20strong%20bias%20towards%20humoral%20immunity%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brett%20H.%22%2C%22lastName%22%3A%22Pogostin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marina%20H.%22%2C%22lastName%22%3A%22Yu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alon%20R.%22%2C%22lastName%22%3A%22Azares%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erin%20M.%22%2C%22lastName%22%3A%22Euliano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cheuk%20Sun%20Edwin%22%2C%22lastName%22%3A%22Lai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriel%22%2C%22lastName%22%3A%22Saenz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%20X.%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20C.%22%2C%22lastName%22%3A%22Farsheed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20M.%22%2C%22lastName%22%3A%22Melhorn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tyler%20P.%22%2C%22lastName%22%3A%22Graf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darren%20G.%22%2C%22lastName%22%3A%22Woodside%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20D.%22%2C%22lastName%22%3A%22Hartgerink%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%20J.%22%2C%22lastName%22%3A%22McHugh%22%7D%5D%2C%22abstractNote%22%3A%22Adjuvants%20play%20a%20critical%20role%20in%20enhancing%20vaccine%20efficacy%3B%20however%2C%20there%20is%20a%20need%20to%20develop%20new%20immunomodulatory%20compounds%20to%20address%20emerging%20pathogens%20and%20to%20expand%20the%20use%20of%20immunotherapies.%20Multidomain%20peptides%20%28MDPs%29%20are%20materials%20composed%20of%20canonical%20amino%20acids%20that%20form%20injectable%20supramolecular%20hydrogels%20under%20physiological%20salt%20and%20pH%20conditions.%20MDP%20hydrogels%20are%20rapidly%20infiltrated%20by%20immune%20cells%20in%20vivo%20and%20have%20previously%20been%20shown%20to%20influence%20cytokine%20production.%20Therefore%2C%20we%20hypothesized%20that%20these%20immunostimulatory%20characteristics%20would%20allow%20MDPs%20to%20function%20as%20vaccine%20adjuvants.%20Herein%2C%20we%20demonstrate%20that%20loading%20antigen%20into%20MDP%20hydrogels%20does%20not%20interfere%20with%20their%20rheological%20properties%20and%20that%20positively%20charged%20MDPs%20can%20act%20as%20antigen%20depots%2C%20as%20demonstrated%20by%20their%20ability%20to%20release%20ovalbumin%20%28OVA%29%20over%20a%20period%20of%207-9%20days%20in%20vivo.%20Mice%20vaccinated%20with%20MDP-adjuvanted%20antigen%20generated%20significantly%20higher%20IgG%20titers%20than%20mice%20treated%20with%20the%20unadjuvanted%20control%2C%20suggesting%20that%20these%20hydrogels%20potentiate%20humoral%20immunity.%20Interestingly%2C%20MDP%20hydrogels%20did%20not%20elicit%20a%20robust%20cellular%20immune%20response%2C%20as%20indicated%20by%20the%20lower%20production%20of%20IgG2c%20and%20smaller%20populations%20of%20tetramer-positive%20CD8%2B%20T%20splenocytes%20compared%20to%20mice%20vaccinated%20alum-adjuvanted%20OVA.%20Together%2C%20the%20data%20suggest%20that%20MDP%20hydrogel%20adjuvants%20strongly%20bias%20the%20immune%20response%20towards%20humoral%20immunity%20while%20evoking%20a%20very%20limited%20cellular%20immune%20response.%20As%20a%20result%2C%20MDPs%20may%20have%20the%20potential%20to%20serve%20as%20adjuvants%20for%20applications%20that%20benefit%20exclusively%20from%20humoral%20immunity.%22%2C%22date%22%3A%22Sept%2014%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1039%5C%2Fd2bm01242a%22%2C%22ISSN%22%3A%222047-4849%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%227XFQVVGN%22%2C%22UWW3ZRC2%22%2C%22C27MTI39%22%5D%2C%22dateModified%22%3A%222022-10-05T15%3A46%3A14Z%22%7D%7D%2C%7B%22key%22%3A%22I7XSBSGG%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hickman%20et%20al.%22%2C%22parsedDate%22%3A%222022-07-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BHickman%2C%20A.%2C%20Koetsier%2C%20J.%2C%20Kurtanich%2C%20T.%20et%20al.%20%282022%29.%20LFA-1%20activation%20enriches%20tumor-specific%20T%20cells%20in%20a%20cold%20tumor%20model%20and%20synergizes%20with%20CTLA-4%20blockade.%20%26lt%3Bi%26gt%3BJ%20Clin%20Invest%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B132%26lt%3B%5C%2Fi%26gt%3B%2C%20e154152.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1172%5C%2FJCI154152%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1172%5C%2FJCI154152%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22LFA-1%20activation%20enriches%20tumor-specific%20T%20cells%20in%20a%20cold%20tumor%20model%20and%20synergizes%20with%20CTLA-4%20blockade%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amber%22%2C%22lastName%22%3A%22Hickman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joost%22%2C%22lastName%22%3A%22Koetsier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Trevin%22%2C%22lastName%22%3A%22Kurtanich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20C.%22%2C%22lastName%22%3A%22Nielsen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Glenn%22%2C%22lastName%22%3A%22Winn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yunfei%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salah-Eddine%22%2C%22lastName%22%3A%22Bentebibel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leilei%22%2C%22lastName%22%3A%22Shi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simone%22%2C%22lastName%22%3A%22Punt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leila%22%2C%22lastName%22%3A%22Williams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cara%22%2C%22lastName%22%3A%22Haymaker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20B.%22%2C%22lastName%22%3A%22Chesson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faisal%22%2C%22lastName%22%3A%22Fa%27ak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%20L.%22%2C%22lastName%22%3A%22Dominguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Jones%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isere%22%2C%22lastName%22%3A%22Kuiatse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%20R.%22%2C%22lastName%22%3A%22Caivano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sayadeth%22%2C%22lastName%22%3A%22Khounlo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Navin%20D.%22%2C%22lastName%22%3A%22Warier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Upendra%22%2C%22lastName%22%3A%22Marathi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20V.%22%2C%22lastName%22%3A%22Market%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ronald%20J.%22%2C%22lastName%22%3A%22Biediger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20W.%22%2C%22lastName%22%3A%22Craft%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%22%2C%22lastName%22%3A%22Hwu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20A.%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darren%20G.%22%2C%22lastName%22%3A%22Woodside%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Vanderslice%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adi%22%2C%22lastName%22%3A%22Diab%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Willem%20W.%22%2C%22lastName%22%3A%22Overwijk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yared%22%2C%22lastName%22%3A%22Hailemichael%22%7D%5D%2C%22abstractNote%22%3A%22The%20inability%20of%20CD8%2B%20effector%20T%20cells%20%28Teffs%29%20to%20reach%20tumor%20cells%20is%20an%20important%20aspect%20of%20tumor%20resistance%20to%20cancer%20immunotherapy.%20The%20recruitment%20of%20these%20cells%20to%20the%20tumor%20microenvironment%20%28TME%29%20is%20regulated%20by%20integrins%2C%20a%20family%20of%20adhesion%20molecules%20that%20are%20expressed%20on%20T%20cells.%20Here%2C%20we%20show%20that%207HP349%2C%20a%20small-molecule%20activator%20of%20lymphocyte%20function-associated%20antigen-1%20%28LFA-1%29%20and%20very%20late%20activation%20antigen-4%20%28VLA-4%29%20integrin%20cell-adhesion%20receptors%2C%20facilitated%20the%20preferential%20localization%20of%20tumor-specific%20T%20cells%20to%20the%20tumor%20and%20improved%20antitumor%20response.%207HP349%20monotherapy%20had%20modest%20effects%20on%20anti-programmed%20death%201-resistant%20%28anti-PD-1-resistant%29%20tumors%2C%20whereas%20combinatorial%20treatment%20with%20anti-cytotoxic%20T%20lymphocyte-associated%20protein%204%20%28anti-CTLA-4%29%20increased%20CD8%2B%20Teff%20intratumoral%20sequestration%20and%20synergized%20in%20cooperation%20with%20neutrophils%20in%20inducing%20cancer%20regression.%207HP349%20intratumoral%20CD8%2B%20Teff%20enrichment%20activity%20depended%20on%20CXCL12.%20We%20analyzed%20gene%20expression%20profiles%20using%20RNA%20from%20baseline%20and%20on%20treatment%20tumor%20samples%20of%2014%20melanoma%20patients.%20We%20identified%20baseline%20CXCL12%20gene%20expression%20as%20possibly%20improving%20the%20likelihood%20or%20response%20to%20anti-CTLA-4%20therapies.%20Our%20results%20provide%20a%20proof-of-principle%20demonstration%20that%20LFA-1%20activation%20could%20convert%20a%20T%20cell-exclusionary%20TME%20to%20a%20T%20cell-enriched%20TME%20through%20mechanisms%20involving%20cooperation%20with%20innate%20immune%20cells.%22%2C%22date%22%3A%22July%2001%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1172%5C%2FJCI154152%22%2C%22ISSN%22%3A%221558-8238%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%226MADD4J5%22%2C%22BBMMGS3D%22%2C%227XFQVVGN%22%2C%224R4R39JD%22%2C%227STYFUFZ%22%2C%225QIRWFUY%22%2C%22TC3LQMP8%22%2C%222RCWVZ4F%22%5D%2C%22dateModified%22%3A%222022-08-02T14%3A41%3A07Z%22%7D%7D%2C%7B%22key%22%3A%227TUX9HBZ%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lokugamage%20et%20al.%22%2C%22parsedDate%22%3A%222021-09-08%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLokugamage%2C%20N.%2C%20Chowdhury%2C%20I.%20H.%2C%20Biediger%2C%20R.%20J.%20et%20al.%20%282021%29.%20Use%20of%20a%20small%20molecule%20integrin%20activator%20as%20a%20systemically%20administered%20vaccine%20adjuvant%20in%20controlling%20Chagas%20disease.%20%26lt%3Bi%26gt%3BNPJ%20Vaccines%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B6%26lt%3B%5C%2Fi%26gt%3B%2C%20114.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41541-021-00378-5%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41541-021-00378-5%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Use%20of%20a%20small%20molecule%20integrin%20activator%20as%20a%20systemically%20administered%20vaccine%20adjuvant%20in%20controlling%20Chagas%20disease%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nandadeva%22%2C%22lastName%22%3A%22Lokugamage%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Imran%20H.%22%2C%22lastName%22%3A%22Chowdhury%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ronald%20J.%22%2C%22lastName%22%3A%22Biediger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20V.%22%2C%22lastName%22%3A%22Market%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sayadeth%22%2C%22lastName%22%3A%22Khounlo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Navin%20D.%22%2C%22lastName%22%3A%22Warier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shen-An%22%2C%22lastName%22%3A%22Hwang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20K.%22%2C%22lastName%22%3A%22Actor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darren%20G.%22%2C%22lastName%22%3A%22Woodside%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Upendra%22%2C%22lastName%22%3A%22Marathi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Vanderslice%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nisha%20Jain%22%2C%22lastName%22%3A%22Garg%22%7D%5D%2C%22abstractNote%22%3A%22The%20development%20of%20suitable%20safe%20adjuvants%20to%20enhance%20appropriate%20antigen-driven%20immune%20responses%20remains%20a%20challenge.%20Here%20we%20describe%20the%20adjuvant%20properties%20of%20a%20small%20molecule%20activator%20of%20the%20integrins%20%5Cu03b1L%5Cu03b22%20and%20%5Cu03b14%5Cu03b21%2C%20named%207HP349%2C%20which%20can%20be%20safely%20delivered%20systemically%20independent%20of%20antigen.%207HP349%20directly%20activates%20integrin%20cell%20adhesion%20receptors%20crucial%20for%20the%20generation%20of%20an%20immune%20response.%20When%20delivered%20systemically%20in%20a%20model%20of%20Chagas%20disease%20following%20immunization%20with%20a%20DNA%20subunit%20vaccine%20encoding%20candidate%20T.%20cruzi%20antigens%2C%20TcG2%20and%20TcG4%2C%207HP349%20enhanced%20the%20vaccine%20efficacy%20in%20both%20prophylactic%20and%20therapeutic%20settings.%20In%20a%20prophylactic%20setting%2C%20mice%20immunized%20with%207HP349%20adjuvanted%20vaccine%20exhibited%20significantly%20improved%20control%20of%20acute%20parasite%20burden%20in%20cardiac%20and%20skeletal%20muscle%20as%20compared%20to%20vaccination%20alone.%20When%20administered%20with%20vaccine%20therapeutically%2C%20parasite%20burden%20was%20again%20decreased%2C%20with%20the%20greatest%20adjuvant%20effect%20of%207HP349%20being%20noted%20in%20skeletal%20muscle.%20In%20both%20settings%2C%20adjuvantation%20with%207HP349%20was%20effective%20in%20decreasing%20pathological%20inflammatory%20infiltrate%2C%20improving%20the%20integrity%20of%20tissue%2C%20and%20controlling%20tissue%20fibrosis%20in%20the%20heart%20and%20skeletal%20muscle%20of%20acutely%20and%20chronically%20infected%20Chagas%20mice.%20The%20positive%20effects%20correlated%20with%20increased%20splenic%20frequencies%20of%20CD8%2BT%20effector%20cells%20and%20an%20increase%20in%20the%20production%20of%20IFN-%5Cu03b3%20and%20cytolytic%20molecules%20%28perforin%20and%20granzyme%29%20by%20the%20CD4%2B%20and%20CD8%2B%20effector%20and%20central%20memory%20subsets%20in%20response%20to%20challenge%20infection.%20This%20demonstrates%20that%207HP349%20can%20serve%20as%20a%20systemically%20administered%20adjuvant%20to%20enhance%20T%20cell-mediated%20immune%20responses%20to%20vaccines.%20This%20approach%20could%20be%20applied%20to%20numerous%20vaccines%20with%20no%20reformulation%20of%20existing%20stockpiles.%22%2C%22date%22%3A%22Sept%2008%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41541-021-00378-5%22%2C%22ISSN%22%3A%222059-0105%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%226MADD4J5%22%2C%22BBMMGS3D%22%2C%227XFQVVGN%22%2C%227STYFUFZ%22%2C%225QIRWFUY%22%2C%22TC3LQMP8%22%5D%2C%22dateModified%22%3A%222021-10-07T18%3A11%3A58Z%22%7D%7D%2C%7B%22key%22%3A%225XAMIK4N%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lopez-Silva%20et%20al.%22%2C%22parsedDate%22%3A%222020-02%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLopez-Silva%2C%20T.%20L.%2C%20Leach%2C%20D.%20G.%2C%20Azares%2C%20A.%20et%20al.%20%282020%29.%20Chemical%20functionality%20of%20multidomain%20peptide%20hydrogels%20governs%20early%20host%20immune%20response.%20%26lt%3Bi%26gt%3BBiomaterials%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B231%26lt%3B%5C%2Fi%26gt%3B%2C%20119667.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.biomaterials.2019.119667%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.biomaterials.2019.119667%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Chemical%20functionality%20of%20multidomain%20peptide%20hydrogels%20governs%20early%20host%20immune%20response%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tania%20L.%22%2C%22lastName%22%3A%22Lopez-Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20G.%22%2C%22lastName%22%3A%22Leach%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alon%22%2C%22lastName%22%3A%22Azares%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22I.-Che%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darren%20G.%22%2C%22lastName%22%3A%22Woodside%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20D.%22%2C%22lastName%22%3A%22Hartgerink%22%7D%5D%2C%22abstractNote%22%3A%22Multidomain%20Peptide%20%28MDP%29%20hydrogels%20are%20nanofibrous%20materials%20with%20many%20potential%20biomedical%20applications.%20The%20peptide%20sequence%20design%20of%20these%20materials%20offers%20high%20versatility%20and%20allows%20for%20the%20incorporation%20of%20various%20chemical%20functionalities%20into%20the%20nanofibrous%20scaffold.%20It%20is%20known%20that%20host%20response%20to%20biomaterials%20is%20strongly%20affected%20by%20factors%20such%20as%20size%2C%20shape%2C%20stiffness%2C%20and%20chemistry.%20However%2C%20there%20is%20a%20lack%20of%20fundamental%20understanding%20of%20the%20host%20response%20to%20different%20MDP%20hydrogels.%20In%20particular%2C%20it%20is%20unknown%20what%20effect%20the%20chemical%20functionality%20displayed%20on%20the%20nanofiber%20has%20on%20biological%20activity.%20Here%20we%20evaluated%20the%20early%20inflammatory%20host%20response%20to%20four%20MDP%20hydrogels%20displaying%20amines%2C%20guanidinium%20ions%2C%20and%20carboxylates%20in%20a%20subcutaneous%20injection%20model.%20While%20all%20the%20studied%20peptide%20materials%20possess%20similar%20nanostructure%20and%20physical%20properties%2C%20they%20trigger%20markedly%20different%20inflammatory%20responses.%20These%20were%20characterized%20by%20immunophenotyping%20of%20the%20cellular%20infiltrate%20using%20multi-color%20flow%20cytometry.%20The%20negatively-charged%20peptides%20elicit%20minimal%20inflammation%20characterized%20by%20tissue-resident%20macrophage%20infiltration%2C%20fast%20remodeling%2C%20and%20no%20collagen%20deposition%20or%20blood%20vessel%20formation%20within%20the%20implants.%20In%20contrast%2C%20the%20positively-charged%20peptides%20are%20highly%20infiltrated%20by%20immune%20cells%2C%20are%20remodeled%20at%20a%20slower%20rate%2C%20promote%20angiogenesis%2C%20and%20result%20in%20a%20high%20degree%20of%20collagen%20deposition.%20The%20presence%20of%20dynamic%20cell%20phenotypes%20characterizes%20the%20inflammation%20caused%20by%20the%20lysine-based%20peptide%2C%20including%20inflammatory%20monocytes%2C%20macrophages%2C%20and%20lymphoid%20cells%2C%20which%20is%20seen%20to%20be%20resolving%20over%20time.%20The%20arginine-based%20hydrogel%20shows%20higher%20inflammatory%20response%20with%20a%20persistent%20and%20significant%20infiltration%20of%20polymorphonuclear%20myeloid-derived%20cells%2C%20even%20ten%20days%20after%20implantation.%20This%20understanding%20of%20the%20immune%20response%20to%20peptide%20biomaterials%20improves%20our%20ability%20to%20design%20effective%20materials%20and%20to%20tailor%20their%20use%20for%20specific%20biomedical%20applications.%22%2C%22date%22%3A%22Feb%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.biomaterials.2019.119667%22%2C%22ISSN%22%3A%221878-5905%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%227XFQVVGN%22%2C%22UWW3ZRC2%22%5D%2C%22dateModified%22%3A%222020-01-14T21%3A21%3A16Z%22%7D%7D%2C%7B%22key%22%3A%22HH4AD2YI%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bakthavatsalam%20et%20al.%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBakthavatsalam%2C%20D.%2C%20Craft%2C%20J.%20W.%2C%20Kazansky%2C%20A.%20et%20al.%20%282020%29.%20Identification%20of%20Inhibitors%20of%20Integrin%20Cytoplasmic%20Domain%20Interactions%20With%20Syk.%20%26lt%3Bi%26gt%3BFront%20Immunol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B11%26lt%3B%5C%2Fi%26gt%3B%2C%20575085.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffimmu.2020.575085%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffimmu.2020.575085%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Identification%20of%20Inhibitors%20of%20Integrin%20Cytoplasmic%20Domain%20Interactions%20With%20Syk%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deenadayalan%22%2C%22lastName%22%3A%22Bakthavatsalam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20W.%22%2C%22lastName%22%3A%22Craft%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%22%2C%22lastName%22%3A%22Kazansky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nghi%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Goeun%22%2C%22lastName%22%3A%22Bae%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%20R.%22%2C%22lastName%22%3A%22Caivano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20William%22%2C%22lastName%22%3A%22Gundlach%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Asra%22%2C%22lastName%22%3A%22Aslam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Safa%22%2C%22lastName%22%3A%22Ali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shashikant%22%2C%22lastName%22%3A%22Gupta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sophie%20Y.%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hema%20D.%22%2C%22lastName%22%3A%22Parthiban%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Vanderslice%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clifford%20C.%22%2C%22lastName%22%3A%22Stephan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darren%20G.%22%2C%22lastName%22%3A%22Woodside%22%7D%5D%2C%22abstractNote%22%3A%22Leukocyte%20inflammatory%20responses%20require%20integrin%20cell-adhesion%20molecule%20signaling%20through%20spleen%20tyrosine%20kinase%20%28Syk%29%2C%20a%20non-receptor%20kinase%20that%20binds%20directly%20to%20integrin%20%5Cu03b2-chain%20cytoplasmic%20domains.%20Here%2C%20we%20developed%20a%20high-throughput%20screen%20to%20identify%20small%20molecule%20inhibitors%20of%20the%20Syk-integrin%20cytoplasmic%20domain%20interactions.%20Screening%20small%20molecule%20compound%20libraries%20identified%20the%20%5Cu03b2-lactam%20antibiotics%20cefsulodin%20and%20ceftazidime%2C%20which%20inhibited%20integrin%20%5Cu03b2-subunit%20cytoplasmic%20domain%20binding%20to%20the%20tandem%20SH2%20domains%20of%20Syk%20%28IC50%20range%2C%201.02-4.9%20%5Cu00b5M%29.%20Modeling%20suggested%20antagonist%20binding%20to%20Syk%20outside%20the%20pITAM%20binding%20site.%20Ceftazidime%20inhibited%20integrin%20signaling%20via%20Syk%2C%20including%20inhibition%20of%20adhesion-dependent%20upregulation%20of%20interleukin-1%5Cu03b2%20and%20monocyte%20chemoattractant%20protein-1%2C%20but%20did%20not%20inhibit%20ITAM-dependent%20phosphorylation%20of%20Syk%20mediated%20by%20Fc%5Cu03b3RI%20signaling.%20Our%20results%20demonstrate%20a%20novel%20means%20to%20target%20Syk%20independent%20of%20its%20kinase%20and%20pITAM%20binding%20sites%20such%20that%20integrin%20signaling%20via%20this%20kinase%20is%20abrogated%20but%20ITAM-dependent%20signaling%20remains%20intact.%20As%20integrin%20signaling%20through%20Syk%20is%20essential%20for%20leukocyte%20activation%2C%20this%20may%20represent%20a%20novel%20approach%20to%20target%20inflammation.%22%2C%22date%22%3A%222020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffimmu.2020.575085%22%2C%22ISSN%22%3A%221664-3224%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22BBMMGS3D%22%2C%227XFQVVGN%22%2C%22VXDM6BAE%22%2C%224R4R39JD%22%2C%22XCUHKMZU%22%5D%2C%22dateModified%22%3A%222021-02-11T18%3A41%3A01Z%22%7D%7D%2C%7B%22key%22%3A%22LGSXCJHD%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Woodside%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bstrong%26gt%3BWoodside%26lt%3B%5C%2Fstrong%26gt%3B%2C%20D.%20G.%20%282019%29.%20Nanoparticle%20imaging%20of%20vascular%20inflammation%20and%20remodeling%20in%20atherosclerotic%20disease.%20%26lt%3Bi%26gt%3BCurrent%20Cardiovascular%20Imaging%20Reports%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B12%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs12410-019-9501-9%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs12410-019-9501-9%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Nanoparticle%20imaging%20of%20vascular%20inflammation%20and%20remodeling%20in%20atherosclerotic%20disease%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darren%20G.%22%2C%22lastName%22%3A%22Woodside%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%227%5C%2F2019%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1007%5C%2Fs12410-019-9501-9%22%2C%22ISSN%22%3A%221941-9066%2C%201941-9074%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Flink.springer.com%5C%2F10.1007%5C%2Fs12410-019-9501-9%22%2C%22collections%22%3A%5B%227XFQVVGN%22%5D%2C%22dateModified%22%3A%222019-07-15T15%3A58%3A47Z%22%7D%7D%2C%7B%22key%22%3A%229LRIQ9XJ%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Woodside%20et%20al.%22%2C%22parsedDate%22%3A%222018-02-27%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bstrong%26gt%3BWoodside%26lt%3B%5C%2Fstrong%26gt%3B%2C%20D.%20G.%2C%20Tanifum%2C%20E.%20A.%2C%20Ghaghada%2C%20K.%20B.%20et%20al.%20%282018%29.%20Magnetic%20resonance%20imaging%20of%20atherosclerotic%20plaque%20at%20clinically%20relevant%20field%20strengths%20%281T%29%20by%20targeting%20the%20integrin%20%26%23x3B1%3B4%26%23x3B2%3B1.%20%26lt%3Bi%26gt%3BSci%20Rep%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B8%26lt%3B%5C%2Fi%26gt%3B%2C%203733.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41598-018-21893-x%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41598-018-21893-x%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Magnetic%20resonance%20imaging%20of%20atherosclerotic%20plaque%20at%20clinically%20relevant%20field%20strengths%20%281T%29%20by%20targeting%20the%20integrin%20%5Cu03b14%5Cu03b21%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darren%20G.%22%2C%22lastName%22%3A%22Woodside%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%20A.%22%2C%22lastName%22%3A%22Tanifum%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ketan%20B.%22%2C%22lastName%22%3A%22Ghaghada%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ronald%20J.%22%2C%22lastName%22%3A%22Biediger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%20R.%22%2C%22lastName%22%3A%22Caivano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zbigniew%20A.%22%2C%22lastName%22%3A%22Starosolski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sayadeth%22%2C%22lastName%22%3A%22Khounlo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Saakshi%22%2C%22lastName%22%3A%22Bhayana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shahrzad%22%2C%22lastName%22%3A%22Abbasi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20W.%22%2C%22lastName%22%3A%22Craft%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20S.%22%2C%22lastName%22%3A%22Maxwell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chandreshkumar%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Igor%20V.%22%2C%22lastName%22%3A%22Stupin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deenadayalan%22%2C%22lastName%22%3A%22Bakthavatsalam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20V.%22%2C%22lastName%22%3A%22Market%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20T.%22%2C%22lastName%22%3A%22Willerson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20A.%20F.%22%2C%22lastName%22%3A%22Dixon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Vanderslice%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ananth%20V.%22%2C%22lastName%22%3A%22Annapragada%22%7D%5D%2C%22abstractNote%22%3A%22Inflammation%20drives%20the%20degradation%20of%20atherosclerotic%20plaque%2C%20yet%20there%20are%20no%20non-invasive%20techniques%20available%20for%20imaging%20overall%20inflammation%20in%20atherosclerotic%20plaques%2C%20especially%20in%20the%20coronary%20arteries.%20To%20address%20this%2C%20we%20have%20developed%20a%20clinically%20relevant%20system%20to%20image%20overall%20inflammatory%20cell%20burden%20in%20plaque.%20Here%2C%20we%20describe%20a%20targeted%20contrast%20agent%20%28THI0567-targeted%20liposomal-Gd%29%20that%20is%20suitable%20for%20magnetic%20resonance%20%28MR%29%20imaging%20and%20binds%20with%20high%20affinity%20and%20selectivity%20to%20the%20integrin%20%5Cu03b14%5Cu03b21%28very%20late%20antigen-4%2C%20VLA-4%29%2C%20a%20key%20integrin%20involved%20in%20recruiting%20inflammatory%20cells%20to%20atherosclerotic%20plaques.%20This%20liposomal%20contrast%20agent%20has%20a%20high%20T1%20relaxivity%20%28~2%5Cu2009%5Cu00d7%5Cu2009105%5Cu2009mM-1s-1%20on%20a%20particle%20basis%29%20resulting%20in%20the%20ability%20to%20image%20liposomes%20at%20a%20clinically%20relevant%20MR%20field%20strength.%20We%20were%20able%20to%20visualize%20atherosclerotic%20plaques%20in%20various%20regions%20of%20the%20aorta%20in%20atherosclerosis-prone%20ApoE-%5C%2F-%20mice%20on%20a%201%20Tesla%20small%20animal%20MRI%20scanner.%20These%20enhanced%20signals%20corresponded%20to%20the%20accumulation%20of%20monocyte%5C%2Fmacrophages%20in%20the%20subendothelial%20layer%20of%20atherosclerotic%20plaques%20in%20vivo%2C%20whereas%20non-targeted%20liposomal%20nanoparticles%20did%20not%20demonstrate%20comparable%20signal%20enhancement.%20An%20inflammatory%20cell-targeted%20method%20that%20has%20the%20specificity%20and%20sensitivity%20to%20measure%20the%20inflammatory%20burden%20of%20a%20plaque%20could%20be%20used%20to%20noninvasively%20identify%20patients%20at%20risk%20of%20an%20acute%20ischemic%20event.%22%2C%22date%22%3A%22Feb%2027%2C%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41598-018-21893-x%22%2C%22ISSN%22%3A%222045-2322%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22NNUFWYNJ%22%2C%226MADD4J5%22%2C%22WGZKEVDQ%22%2C%22BBMMGS3D%22%2C%227XFQVVGN%22%2C%22JH9V95Q8%22%2C%22VXDM6BAE%22%2C%224R4R39JD%22%2C%227STYFUFZ%22%2C%225QIRWFUY%22%5D%2C%22dateModified%22%3A%222018-05-07T19%3A32%3A11Z%22%7D%7D%2C%7B%22key%22%3A%22GECGZIMX%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kumar%20et%20al.%22%2C%22parsedDate%22%3A%222016-08%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKumar%2C%20V.%20A.%2C%20Liu%2C%20Q.%2C%20Wickremasinghe%2C%20N.%20C.%20et%20al.%20%282016%29.%20Treatment%20of%20hind%20limb%20ischemia%20using%20angiogenic%20peptide%20nanofibers.%20%26lt%3Bi%26gt%3BBiomaterials%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B98%26lt%3B%5C%2Fi%26gt%3B%2C%20113%26%23x2013%3B119.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.biomaterials.2016.04.032%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.biomaterials.2016.04.032%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Treatment%20of%20hind%20limb%20ischemia%20using%20angiogenic%20peptide%20nanofibers%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vivek%20A.%22%2C%22lastName%22%3A%22Kumar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qi%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Navindee%20C.%22%2C%22lastName%22%3A%22Wickremasinghe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Siyu%22%2C%22lastName%22%3A%22Shi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Toya%20T.%22%2C%22lastName%22%3A%22Cornwright%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuxiao%22%2C%22lastName%22%3A%22Deng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alon%22%2C%22lastName%22%3A%22Azares%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanda%20N.%22%2C%22lastName%22%3A%22Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanda%20M.%22%2C%22lastName%22%3A%22Acevedo-Jake%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Noel%20R.%22%2C%22lastName%22%3A%22Agudo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Su%22%2C%22lastName%22%3A%22Pan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darren%20G.%22%2C%22lastName%22%3A%22Woodside%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Vanderslice%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20T.%22%2C%22lastName%22%3A%22Willerson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20A.%22%2C%22lastName%22%3A%22Dixon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20D.%22%2C%22lastName%22%3A%22Hartgerink%22%7D%5D%2C%22abstractNote%22%3A%22For%20a%20proangiogenic%20therapy%20to%20be%20successful%2C%20it%20must%20promote%20the%20development%20of%20mature%20vasculature%20for%20rapid%20reperfusion%20of%20ischemic%20tissue.%20Whole%20growth%20factor%2C%20stem%20cell%2C%20and%20gene%20therapies%20have%20yet%20to%20achieve%20the%20clinical%20success%20needed%20to%20become%20FDA-approved%20revascularization%20therapies.%20Herein%2C%20we%20characterize%20a%20biodegradable%20peptide-based%20scaffold%20engineered%20to%20mimic%20VEGF%20and%20self-assemble%20into%20a%20nanofibrous%2C%20thixotropic%20hydrogel%2C%20SLanc.%20We%20found%20that%20this%20injectable%20hydrogel%20was%20rapidly%20infiltrated%20by%20host%20cells%20and%20could%20be%20degraded%20while%20promoting%20the%20generation%20of%20neovessels.%20In%20mice%20with%20induced%20hind%20limb%20ischemia%2C%20this%20synthetic%20peptide%20scaffold%20promoted%20angiogenesis%20and%20ischemic%20tissue%20recovery%2C%20as%20shown%20by%20Doppler-quantified%20limb%20perfusion%20and%20a%20treadmill%20endurance%20test.%20Thirteen-month-old%20mice%20showed%20significant%20recovery%20within%207%20days%20of%20treatment.%20Biodistribution%20studies%20in%20healthy%20mice%20showed%20that%20the%20hydrogel%20is%20safe%20when%20administered%20intramuscularly%2C%20subcutaneously%2C%20or%20intravenously.%20These%20preclinical%20studies%20help%20establish%20the%20efficacy%20of%20this%20treatment%20for%20peripheral%20artery%20disease%20due%20to%20diminished%20microvascular%20perfusion%2C%20a%20necessary%20step%20before%20clinical%20translation.%20This%20peptide-based%20approach%20eliminates%20the%20need%20for%20cell%20transplantation%20or%20viral%20gene%20transfection%20%28therapies%20currently%20being%20assessed%20in%20clinical%20trials%29%20and%20could%20be%20a%20more%20effective%20regenerative%20medicine%20approach%20to%20microvascular%20tissue%20engineering.%22%2C%22date%22%3A%22Aug%202016%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.biomaterials.2016.04.032%22%2C%22ISSN%22%3A%221878-5905%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22NNUFWYNJ%22%2C%22WGZKEVDQ%22%2C%22BBMMGS3D%22%2C%227XFQVVGN%22%2C%22LV239TYN%22%2C%22UWW3ZRC2%22%2C%22CH4JXISP%22%5D%2C%22dateModified%22%3A%222018-05-02T21%3A21%3A07Z%22%7D%7D%2C%7B%22key%22%3A%22NNXKW22X%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Deng%20et%20al.%22%2C%22parsedDate%22%3A%222016-04-15%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BDeng%2C%20Y.%2C%20Yang%2C%20Z.%2C%20Terry%2C%20T.%20et%20al.%20%282016%29.%20Prostacyclin-producing%20human%20mesenchymal%20cells%20target%20H19%20lncRNA%20to%20augment%20endogenous%20progenitor%20function%20in%20hindlimb%20ischaemia.%20%26lt%3Bi%26gt%3BNat%20Commun%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B7%26lt%3B%5C%2Fi%26gt%3B%2C%2011276.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fncomms11276%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fncomms11276%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Prostacyclin-producing%20human%20mesenchymal%20cells%20target%20H19%20lncRNA%20to%20augment%20endogenous%20progenitor%20function%20in%20hindlimb%20ischaemia%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuxiao%22%2C%22lastName%22%3A%22Deng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhongwei%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Toya%22%2C%22lastName%22%3A%22Terry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Su%22%2C%22lastName%22%3A%22Pan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darren%20G.%22%2C%22lastName%22%3A%22Woodside%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jingxiong%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kehe%22%2C%22lastName%22%3A%22Ruan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20T.%22%2C%22lastName%22%3A%22Willerson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20A.%20F.%22%2C%22lastName%22%3A%22Dixon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qi%22%2C%22lastName%22%3A%22Liu%22%7D%5D%2C%22abstractNote%22%3A%22Promoting%20the%20paracrine%20effects%20of%20human%20mesenchymal%20stem%20cell%20%28hMSC%29%20therapy%20may%20contribute%20to%20improvements%20in%20patient%20outcomes.%20Here%20we%20develop%20an%20innovative%20strategy%20to%20enhance%20the%20paracrine%20effects%20of%20hMSCs.%20In%20a%20mouse%20hindlimb%20ischaemia%20model%2C%20we%20examine%20the%20effects%20of%20hMSCs%20in%20which%20a%20novel%20triple-catalytic%20enzyme%20is%20introduced%20to%20stably%20produce%20prostacyclin%20%28PGI2-hMSCs%29.%20We%20show%20that%20PGI2-hMSCs%20facilitate%20perfusion%20recovery%20and%20enhance%20running%20capability%20as%20compared%20with%20control%20hMSCs%20or%20iloprost%20%28a%20stable%20PGI2%20analogue%29.%20Transplanted%20PGI2-hMSCs%20do%20not%20incorporate%20long%20term%20into%20host%20tissue%2C%20but%20rather%20they%20mediate%20host%20regeneration%20and%20muscle%20mass%20gain%20in%20a%20paracrine%20manner.%20Mechanistically%2C%20this%20involves%20long%20noncoding%20RNA%20H19%20in%20promoting%20PGI2-hMSC-associated%20survival%20and%20proliferation%20of%20host%20progenitor%20cells%20under%20hypoxic%20conditions.%20Together%2C%20our%20data%20reveal%20the%20novel%20ability%20of%20PGI2-hMSCs%20to%20stimulate%20host%20regenerative%20processes%20and%20improve%20physical%20function%20by%20regulating%20long%20noncoding%20RNA%20in%20resident%20progenitor%20cells.%22%2C%22date%22%3A%22Apr%2015%2C%202016%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fncomms11276%22%2C%22ISSN%22%3A%222041-1723%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22NNUFWYNJ%22%2C%22WGZKEVDQ%22%2C%2256KGJLQK%22%2C%227XFQVVGN%22%2C%22LV239TYN%22%2C%22CH4JXISP%22%5D%2C%22dateModified%22%3A%222018-05-02T21%3A08%3A45Z%22%7D%7D%2C%7B%22key%22%3A%22TETNSVGW%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bakthavatsalam%20et%20al.%22%2C%22parsedDate%22%3A%222014-06-13%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBakthavatsalam%2C%20D.%2C%20Soung%2C%20R.%20H.%2C%20Tweardy%2C%20D.%20J.%20et%20al.%20%282014%29.%20Chaperonin-containing%20TCP-1%20complex%20directly%20binds%20to%20the%20cytoplasmic%20domain%20of%20the%20LOX-1%20receptor.%20%26lt%3Bi%26gt%3BFEBS%20Lett%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B588%26lt%3B%5C%2Fi%26gt%3B%2C%202133%26%23x2013%3B2140.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.febslet.2014.04.049%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.febslet.2014.04.049%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Chaperonin-containing%20TCP-1%20complex%20directly%20binds%20to%20the%20cytoplasmic%20domain%20of%20the%20LOX-1%20receptor%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deenadayalan%22%2C%22lastName%22%3A%22Bakthavatsalam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roh%20Hun%22%2C%22lastName%22%3A%22Soung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20J.%22%2C%22lastName%22%3A%22Tweardy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wah%22%2C%22lastName%22%3A%22Chiu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20A.%20F.%22%2C%22lastName%22%3A%22Dixon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darren%20G.%22%2C%22lastName%22%3A%22Woodside%22%7D%5D%2C%22abstractNote%22%3A%22Lectin-like%20oxidized%20low-density%20lipoprotein%20receptor%20%28LOX-1%29%20is%20a%20scavenger%20receptor%20that%20binds%20oxidized%20low-density%20lipoprotein%20%28OxLDL%29%20and%20has%20a%20role%20in%20atherosclerosis%20development.%20The%20N-terminus%20intracellular%20region%20%28cytoplasmic%20domain%29%20of%20LOX-1%20mediates%20receptor%20internalization%20and%20trafficking%2C%20potentially%20through%20intracellular%20protein%20interactions.%20Using%20affinity%20isolation%2C%20we%20identified%206%20of%20the%208%20components%20of%20the%20chaperonin-containing%20TCP-1%20%28CCT%29%20complex%20bound%20to%20LOX-1%20cytoplasmic%20domain%2C%20which%20we%20verified%20by%20coimmunoprecipitation%20and%20immunostaining%20in%20human%20umbilical%20vein%20endothelial%20cells.%20We%20found%20that%20the%20interaction%20between%20CCT%20and%20LOX-1%20is%20direct%20and%20ATP-dependent%20and%20that%20OxLDL%20suppressed%20this%20interaction.%20Understanding%20the%20association%20between%20LOX-1%20and%20the%20CCT%20complex%20may%20facilitate%20the%20design%20of%20novel%20therapies%20for%20cardiovascular%20disease.%22%2C%22date%22%3A%22Jun%2013%2C%202014%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.febslet.2014.04.049%22%2C%22ISSN%22%3A%221873-3468%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22WGZKEVDQ%22%2C%227XFQVVGN%22%2C%22VXDM6BAE%22%5D%2C%22dateModified%22%3A%222018-05-02T20%3A28%3A49Z%22%7D%7D%5D%7D
Pogostin, B.H., Yu, M.H., Azares, A.R. et al. (2022). Multidomæne peptidhydrogeladjuvanser fremkalder stærk bias mod humoral immunitet. Biomater Sci. https://doi.org/10.1039/d2bm01242a.
Hickman, A., Koetsier, J., Kurtanich, T. et al. (2022). LFA-1-aktivering beriger tumorspecifikke T-celler i en kold tumormodel og synergerer med CTLA-4-blokade. J Clin Invest 132, e154152. https://doi.org/10.1172/JCI154152.
Lokugamage, N., Chowdhury, I.H., Biediger, R.J. et al. (2021). Anvendelse af en integrinaktivator med lille molekyle som en systemisk administreret vaccineadjuvans til at kontrollere Chagas sygdom. NPJ-vacciner 6, 114. https://doi.org/10.1038/s41541-021-00378-5.
Lopez-Silva, T.L., Leach, D.G., Azares, A. et al. (2020). Kemisk funktionalitet af multidomæne peptidhydrogeler styrer tidlig værtsimmunrespons. biomaterialer 231, 119667. https://doi.org/10.1016/j.biomaterials.2019.119667.
Bakthavatsalam, D., Craft, JW, Kazansky, A. et al. (2020). Identifikation af inhibitorer af integrin cytoplasmatisk domæne interaktioner med Syk. Front Immunol 11, 575085. https://doi.org/10.3389/fimmu.2020.575085.
Woodside, D.G. (2019). Nanopartikelbilleddannelse af vaskulær inflammation og ombygning ved aterosklerotisk sygdom. Aktuelle kardiovaskulær billeddannelsesrapporter 12. https://doi.org/10.1007/s12410-019-9501-9.
Woodside, D. G., Tanifum, E. A., Ghaghada, K. B. et al. (2018). Magnetisk resonansbilleddannelse af aterosklerotisk plak ved klinisk relevante feltstyrker (1T) ved at målrette mod integrinet α4β1. Sci Rep 8, 3733. https://doi.org/10.1038/s41598-018-21893-x.
Kumar, V.A., Liu, Q., Wickremasinghe, N.C. et al. (2016). Behandling af iskæmi i bagben ved hjælp af angiogene peptidnanofibre. biomaterialer 98, 113-119. https://doi.org/10.1016/j.biomaterials.2016.04.032.
Deng, Y., Yang, Z., Terry, T. et al. (2016). Prostacyclin-producerende humane mesenkymale celler målretter mod H19 lncRNA for at øge endogen progenitorfunktion i bagbensiskæmi. Nat Commun 7, 11276. https://doi.org/10.1038/ncomms11276.
Bakthavatsalam, D., Soung, R.H., Twaardy, D.J. et al. (2014). Chaperonin-holdigt TCP-1-kompleks binder direkte til det cytoplasmatiske domæne af LOX-1-receptoren. FEBS Lett 588, 2133-2140. https://doi.org/10.1016/j.febslet.2014.04.049.
Seneste nyheder
Texas Heart Institute udnævner Dr. Yaxin Wang til den første kvindelige begavede stol for innovative anordninger og ingeniørapplikationer
Texas Heart Institute er stolte af at annoncere Yaxin Wang, ph.d., som John S. Dunn Begavet Chair i Innovative...
Forskning Socialt leverer dynamisk eftermiddag med fokus på kollaborativ videnskab
Den 20. november 2024 afholdt The Texas Heart Institute (THI) sin første Research Social nogensinde, hvilket markerede et markant skift fra traditionelle...
7 Hills Pharma annoncerer første patient i fase 1b/2a klinisk forsøg, der tester Alintegimod mod aPD-1-resistente solide tumorer
Texas Heart Institute er glade for at dele de banebrydende fremskridt for 7 Hills Pharma Inc. ("7 Hills"), en klinisk fase...
